Top Industry Leaders in the Pain Relief Medication Market
Latest Pain Relief Medication Companies Update:
Pfizer Received FDA approval for Dutodiril (Lyrica Pregabalin) in October 2023, a fixed-dose combination therapy for fibromyalgia pain.
Johnson & Johnson Announced the expansion of its PainShield™ technology in November 2023, offering non-invasive, personalized pain relief through electrical stimulation.
Novartis AG Partnered with a biotech company in December 2023 to develop novel pain therapeutics targeting specific pain pathways and potentially reducing opioid dependence.
Eli Lilly and Company Received positive Phase 2 trial results for its galcanezumab-durvalumab combination therapy for chronic migraine prevention in January 2024, raising hopes for a groundbreaking treatment.
Bayer AG Launched its QoviPro™ patch in February 2024, a long-acting fentanyl patch offering improved pain management for chronic pain patients who require opioid therapy.
List of Pain Relief Medication Key companies in the market
- Nestle
- JM Smucker Company
- The Kraft Heinz Company
- Starbucks Pain Relief Medication Company